IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MUHAMMAD OVAIS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1376236224
CMS profile
11509156
Location
WELDON SPRING, MO

General Payments · PY2023–2024

$1,272.02

  • Reported across 67 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$951.87

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health MO All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $904.11 47
Education $47.76 4

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $352.77 22
Vanda Pharmaceuticals Inc. $267.82 10
E.R. Squibb & Sons, L.L.C. $143.12 11
Neurocrine BioSciences, Inc. $82.36 4
ABBVIE INC. $78.79 3
Otsuka America Pharmaceutical, Inc. $27.01 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $320.15 16
PY2024 $951.87 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $29.21 05/30/2024 Food and Beverage Undisputed 01/23/2026 1107773626 CMS
ABBVIE INC. $20.72 08/21/2024 Food and Beverage Undisputed 01/23/2026 1107773628 CMS
ABBVIE INC. $28.86 09/19/2024 Food and Beverage Undisputed 01/23/2026 1107773630 CMS
E.R. Squibb & Sons, L.L.C. $7.44 08/30/2024 Food and Beverage Undisputed 01/23/2026 1101234863 CMS
E.R. Squibb & Sons, L.L.C. $15.72 09/13/2024 Food and Beverage Undisputed 01/23/2026 1101234867 CMS
E.R. Squibb & Sons, L.L.C. $6.08 10/09/2024 Food and Beverage Undisputed 01/23/2026 1101234869 CMS
E.R. Squibb & Sons, L.L.C. $2.90 10/25/2024 Food and Beverage Undisputed 01/23/2026 1101234883 CMS
E.R. Squibb & Sons, L.L.C. $23.62 10/25/2024 Food and Beverage Undisputed 01/23/2026 1101234885 CMS
E.R. Squibb & Sons, L.L.C. $15.45 10/31/2024 Food and Beverage Undisputed 01/23/2026 1101234889 CMS
E.R. Squibb & Sons, L.L.C. $11.57 11/08/2024 Food and Beverage Undisputed 01/23/2026 1101234893 CMS
E.R. Squibb & Sons, L.L.C. $5.99 11/11/2024 Food and Beverage Undisputed 01/23/2026 1101234905 CMS
E.R. Squibb & Sons, L.L.C. $22.48 11/22/2024 Food and Beverage Undisputed 01/23/2026 1101234903 CMS
E.R. Squibb & Sons, L.L.C. $24.56 11/22/2024 Food and Beverage Undisputed 01/23/2026 1101234907 CMS
E.R. Squibb & Sons, L.L.C. $7.31 12/18/2024 Food and Beverage Undisputed 01/23/2026 1101234913 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.41 01/09/2024 Food and Beverage Undisputed 01/23/2026 1143576590 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.40 01/09/2024 Food and Beverage Undisputed 01/23/2026 1143576592 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.13 02/28/2024 Food and Beverage Undisputed 01/23/2026 1143576594 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.05 04/25/2024 Food and Beverage Undisputed 01/23/2026 1143576596 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.71 05/03/2024 Food and Beverage Undisputed 01/23/2026 1143576598 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5.65 05/09/2024 Food and Beverage Undisputed 01/23/2026 1143576600 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.31 05/21/2024 Food and Beverage Undisputed 01/23/2026 1143576602 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.15 06/06/2024 Education Undisputed 01/23/2026 1143576604 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.34 06/06/2024 Food and Beverage Undisputed 01/23/2026 1143576606 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.74 06/27/2024 Food and Beverage Undisputed 01/23/2026 1143576608 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.59 07/12/2024 Food and Beverage Undisputed 01/23/2026 1143576610 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.30 07/19/2024 Food and Beverage Undisputed 01/23/2026 1143576612 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.50 08/02/2024 Food and Beverage Undisputed 01/23/2026 1143576614 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.47 08/27/2024 Food and Beverage Undisputed 01/23/2026 1143576616 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.29 08/28/2024 Food and Beverage Undisputed 01/23/2026 1143576618 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $33.31 09/05/2024 Food and Beverage Undisputed 01/23/2026 1143576620 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.19 09/27/2024 Food and Beverage Undisputed 01/23/2026 1143576622 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $33.87 10/04/2024 Food and Beverage Undisputed 01/23/2026 1143576624 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.38 10/11/2024 Food and Beverage Undisputed 01/23/2026 1143576626 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.10 10/17/2024 Food and Beverage Undisputed 01/23/2026 1143576628 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.72 10/22/2024 Food and Beverage Undisputed 01/23/2026 1143576630 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.16 12/11/2024 Food and Beverage Undisputed 01/23/2026 1143576632 CMS
Neurocrine Biosciences, Inc. $23.75 03/08/2024 Food and Beverage Undisputed 01/23/2026 1150960410 CMS
Neurocrine Biosciences, Inc. $16.78 05/07/2024 Food and Beverage Undisputed 01/23/2026 1150995982 CMS
Neurocrine Biosciences, Inc. $14.83 08/27/2024 Food and Beverage Undisputed 01/23/2026 1151004720 CMS
Neurocrine Biosciences, Inc. $27.00 10/02/2024 Food and Beverage Undisputed 01/23/2026 1150947916 CMS
Otsuka America Pharmaceutical, Inc. $27.01 08/22/2024 Food and Beverage Undisputed 01/23/2026 1119156041 CMS
Vanda Pharmaceuticals Inc. $25.46 05/16/2024 Food and Beverage Undisputed 01/23/2026 1133962553 CMS
Vanda Pharmaceuticals Inc. $11.87 07/15/2024 Education Undisputed 01/23/2026 1133962555 CMS
Vanda Pharmaceuticals Inc. $19.14 07/29/2024 Food and Beverage Undisputed 01/23/2026 1133962557 CMS
Vanda Pharmaceuticals Inc. $11.87 09/13/2024 Food and Beverage Undisputed 01/23/2026 1133962559 CMS
Vanda Pharmaceuticals Inc. $7.57 10/01/2024 Food and Beverage Undisputed 01/23/2026 1133962561 CMS
Vanda Pharmaceuticals Inc. $18.11 10/09/2024 Food and Beverage Undisputed 01/23/2026 1133962563 CMS
Vanda Pharmaceuticals Inc. $11.87 10/16/2024 Education Undisputed 01/23/2026 1133962565 CMS
Vanda Pharmaceuticals Inc. $124.97 11/19/2024 Food and Beverage Undisputed 01/23/2026 1133962567 CMS
Vanda Pharmaceuticals Inc. $25.09 12/06/2024 Food and Beverage Undisputed 01/23/2026 1133962569 CMS
Vanda Pharmaceuticals Inc. $11.87 12/16/2024 Education Undisputed 01/23/2026 1133962571 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.